# K123892: Mepilex Transfer AG

- Pathway: 510(k) (Traditional)
- Applicant: Molnlycke Health Care
- Decided: Apr 5, 2013 after 108 days
- Product code: FRO (Dressing, Wound, Drug)
- Device class: U
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 2 generations back to K061554 (2007). 2 ancestors in all.
2 later devices descend from it; 1 cites it directly.
0 of 5 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K100029: Mepilex Border AG Dressing, Molnlycke Health Care (2010) Summary page 2.

## Most influential descendants
- K123756: Covagen (2013), 1 descendant of its own
- K192346: scaffolene CL100 Bioresorbable Collagen Matrix (2020), 0 descendants of its own

## Indications for use
Mepilex® Transfer Ag dressing is indicated for the management of a wide range of exuding wounds such as leg and foot ulcers, pressure ulcers, partial thickness burns, traumatic and surgical wounds. Mepilex® Transfer Ag can also be used under compression bandaging.

Source page: https://510kreport.com/device/K123892
Methodology: https://510kreport.com/methodology